Theses
Hovedinnhold
Martha Haugstøyl (2022) Immune cell phenotypes in adipose tissue and obesity-associated circulating biomarkers
Elise Grytten (2022) Changes in cardiometabolic risk factors after supplementation with omega-3 and omega-6 fatty acids
Mona S. Bjune (2022) The valine-3-HIB pathway in obesity, insulin resistance and fatty liver
Divya Sri Priyanka Tallapragada (2021) Novel adipose genes in substrate- and depot-dependent lipid accumulation
Regine Åsen Jersin (2020) Role of adipocyte SLC7A10 and amino acid metabolism in obesity
Krisitina Strand (2020) Characterization of adipose tissue and liver innate immune cells in obesity-related insulin resistance.
Christine Haugen (2020) Molecular determinants of obesity and glucose tolerance. The role of IRX3, IRX5 and decorin.
Jan Inge Bjune (2020) Regulation of adipogenesis and fat storage by IRX3 and IRX5.
Vivian Veum (2019) Changes in fat accumulation and metabolic risk parameters during weight loss.
Thomas Helland (2019) Tamoxifen in the treatment of luminal breast cancer - Implications of active metabolites on gene expression, side effects and clinical outcome.
Olivera Bozickovic (2015) Regulation and function of steroid receptor coactivator 2 in hepatoma and breast cancer cells.
Andre Greger Madsen (2015) Function and regulation of Steroid Receptor Coactivator 2. Transcriptional regulation of cellular metabolism.
Monika H. E. Christensen (2013) Primary Hyperpapathyroidism: Effects on Bone and Markers of Inflammation.
Line L. Haugan Moi (2012) Endocrine Treatment of Breast Cancer: Tamoxifen metabolism, steroid receptor coactivators and growth factor receptors.
Marianne Hauglid Flågeng (2011) Steroid Receptor Coactivators and Epidermal Growth Factor Receptors in Breast Cancer.
Simon E Nitter Dankel (2011) Transcriptomics of Adipose Tissue: Integrative Search for Obesity Candidate Genes.
Ingvild Sveinsgjerd Fenne (2008) Regulation of Nuclear Receptor Coactivator GRIP1 by cAMP-Dependent Signaling.
Jennifer Gjerde (2008) Tamoxifen Treatment of Breast Cancer: Pharmacogenetics and Therapeutic Drug Monitoring.
Therese Røst (2008) Peroxisome Proliferator-Activated Receptors (PPARs) and Mitochondria in Relation to Lifestyle-Related Diseases.
Tuyen Thi Van Hoang (2007) Nuclear Receptor Coregulators – Role of Protein-Protein Interactions and cAMP/PKA Signaling.
Pål Holm (2007) Betaine and its Relation to Homocysteine Status and One-Carbon Metabolism in Humans: Analytical Method and Biochemical Studies.
Bjørn Gunnar Nedrebø (2004) Graves’ Disease and Hypothyroidism with Emphasis on Treatment, Homocysteine and B-vitamins.
Elton Richard Kisanga (2004) Pharmacology of Low-Dose Tamoxifen Regiments in Breast Cancer Treatment.
Bente Børud (2002) Transcriptional Regulation by Steroidogenic Factor-1 and Interacting Coregulators.
Johan Arnt Steier (2002) Human Chorionic Gonadotropin (hCG) in Pregnancy: Significance of Fetal Sex on hCG Levels in Maternal Blood.
Hooshang Lahooti (1991) The Estradiol Receptor and the 90 kDa Heat Shock Protein: Phosphorylation of Receptor and the Heat Shock Protein, and Studies on Regulation of the Estradiol Receptor mRNA.
Ole Langeland Myking (1988) Oestrogens in Male Blood, Effect of Age and Fatty Liver: Significance of Hepatic Sulphotransferase for the Levels of Oestrone and Oestrone Sulphate - Clinical and Experimental Studies.
Thor Thorsen (1982) Studies on Steroid Receptors in Human Breast Cancer, with Special Reference to Functional Integrity.
Karl Fr. Støa (1958) Studies on Thiocyanate in Serum: with some Supplementary Investigations in Saliva, Urine, and Cerebrospinal Fluid